Europe, Middle East & Africa
Flexible Design for Novel Trials
Cenduit IRT supports national lung cancer trial
Nov 10, 2020
Cenduit currently provides randomization and trial supply management for the world’s largest precision medicine trial to investigate treatment for non-small cell lung cancer. This trial is investigating genetic biomarker targeted therapy combinations, via partnership between non-profit research organizations and large pharmaceutical companies.
Related Solutions
Interactive Response Technology
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Digital Patient Suite
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
You may also be interested in